September 1, 2006Proceedings of the American Thoracic Society
Pulmonary Microvascular Disease in Chronic Thromboembolic Pulmonary Hypertension
Population
Patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports microvascular assessment for CTEPH operability decisions now; leaves open randomized trials of medical therapy integration.
Structured PICO
P
Population
Patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Understanding the extent and mechanisms of pulmonary microvascular disease in CTEPH is critical for selecting patients for pulmonary endarterectomy and guiding medical therapy.
Cite This Study
Nazzareno Galiè (2006) studied this question.